NATCO Pharma informs about closure of trading window

01 Apr 2023 Evaluate

NATCO Pharma has informed that the Trading Window for dealing in the securities of the Company would remain closed for the Directors, Designated Persons, their immediate relatives and all other connected persons covered in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time with effect from April 1, 2023 to till 48 hours after the declaration of the Financial Results of the Company for the quarter and year ended on March 31, 2023. The date of the Board Meeting for declaration of the financial results of the Company for the quarter and year ended on March 31, 2023 will be intimated in due course of time.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

863.05 -20.45 (-2.31%)
30-Apr-2025 13:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1825.55
Dr. Reddys Lab 1183.50
Cipla 1548.55
Lupin 2091.60
Zydus Lifesciences 889.50
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...